Piper Sandler Downgrades Inspire Medical Systems to Neutral, Lowers Price Target to $55

Benzinga Newsdesk www.benzinga.com Negative 87.8%

Neg 87.8% Neu 0% Pos 0%

Piper Sandler analyst Adam Maeder downgrades Inspire Medical Systems (NYSE:INSP) from Overweight to Neutral and lowers the price target from $85 to $55.